Nirali N. Shah

Jewish General Hospital — Canada

Medicine · Health Sciences

52h-index15.4kcitations427works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(230), Acute Lymphoblastic Leukemia research(90), Hematopoietic Stem Cell Transplantation(56), Immune Cell Function and Interaction(43), Virus-based gene therapy research(38)

Publications427 total

Intraoperative MRI for endoscopic endonasal transsphenoidal surgery in children
Journal of Neurosurgery Pediatrics·2026
Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemia
Blood Advances·2025Open Access
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis
Blood·2025· 2 cited
Parental awareness and practice on malocclusion in Ahmedabad, Gujarat, India: A questionnaire survey
Bioinformation·2025Open Access
From bench to IND: Validation of TSLPR CAR T-cells reveal discrepancies in detection modalities and inform dose selection for a Phase 1 clinical trial in relapsed/refractory CRLF2-rearranged B-ALL patients.
Blood·2025
SPPL3-glycosylation axis governs CD22 CAR T-cell susceptibility in B-ALL independent of antigen recognition
Blood·2025Open Access
Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial)
Blood·2025
A novel immune signature characterized by activation of the IFNγ-IL18 axis identifies immune effector cell-associated HLH-like syndrome after CD22 chimeric antigen receptor T-cell therapy
Blood·2025Open Access
Early use of talicabtagene autoleucel in r/r B-acute lymphoblastic leukemia is cost-effective: Improved efficacy, reduced toxicity and healthcare resource utilization support affordable access
Blood·2025Open Access
Utility of peripheral blood cell-free DNA in detecting minimal residual disease in patients receiving CAR T-cell therapy for B-acute lymphoblastic leukemia (B-ALL)
Blood·2025Open Access
Single-cell metabolic profiling of post-infusion CD22 and CD19/CD22 CAR T-cells reveals a shift toward amino acid–driven oxphos informing SLC-armored CAR design
Blood·2025
Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement
HemaSphere·2025Open Access
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia
Blood Advances·2025· 1 citedOpen Access
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies
Cytotherapy·2025Open Access
Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group
Transplantation and Cellular Therapy·2025Open Access
Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>
Transplantation and Cellular Therapy·2025Open Access
Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers
Transplantation and Cellular Therapy·2025· 3 citedOpen Access
Remission of <i>TP53</i> -Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33)
JCO Precision Oncology·2025
Gene-edited CAR T cells: going the distance in B-ALL
Blood Advances·2025Open Access
Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies
Neurology·2025· 3 citedOpen Access
page 1 of 22Next →

Frequent Co-authors

Terry J. Fry(21), Maryalice Stetler‐Stevenson(17), Constance M. Yuan(17), Bonnie Yates(15), Haneen Shalabi(13), Crystal L. Mackall(11), Cindy Delbrook(10), Daniel W. Lee(10), Haiying Qin(9), Alan S. Wayne(8), David F. Stroncek(8), Seth M. Steinberg(7), Steven L. Highfill(7), Hao‐Wei Wang(7), Pamela L. Wolters(6), Michael A. Pulsipher(6), Staci Martin(5), Jack F. Shern(5), Joshua A. Hill(5), Stephan A. Grupp(5)